Lyme DiseaseSupport Oligonucleotide Therapy
What it is and how it works
Supportive Oligonucleotide Therapy (SOT) is a novel approach to treating Lyme disease, which involves the use of synthetic pieces of DNA called oligonucleotides.
SOT works by targeting specific bacterial genes in the bacteria that cause Lyme disease, binding to them, and preventing the bacteria from producing the proteins necessary for their survival.
Why consider SOT for Lyme Treatment
SOT may offer several potential advantages over conventional antibiotic treatments:
- Targeted approach
- Reduced side effects
- Potential for long-lasting results
- Improved outcomes